Weight Gain and Cardiovascular Risk After Organ Transplantation

Organ transplantation has become a common and effective approach to the management of patients with organ failure. The improvement in long-term survival has resulted in the emergence of cardiovascular disease as the primary cause of death in renal transplant patients and a significant complication i...

Full description

Saved in:
Bibliographic Details
Published in:JPEN. Journal of parenteral and enteral nutrition Vol. 25; no. 3; pp. 114 - 119
Main Author: Baum, Charles L.
Format: Journal Article
Language:English
Published: Thousand Oaks, CA Sage Publications 01-05-2001
SAGE Publications
ASPEN
American Society for Parenteral and Enteral Nutrition
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Organ transplantation has become a common and effective approach to the management of patients with organ failure. The improvement in long-term survival has resulted in the emergence of cardiovascular disease as the primary cause of death in renal transplant patients and a significant complication in other organ recipients. A number of factors explain this trend, including a high incidence of hypertension, posttransplant diabetes, hyperlipidemia, and obesity risk factors that are mediated by direct effects of immunosuppressive medications. Weight gain posttransplant affects ~50% of patients and represents a significant problem because of the potential synergism between obesity and immunosuppressive medication-induced effects on cardiovascular disease risk factor development. This review discusses the incidence and implications of cardiovascular disease risk factors in organ transplant recipients, strategies for clinical management, and future research directions. (Journal of Parenteral and Enteral Nutrition 25:114-119, 2001)
ISSN:0148-6071
1941-2444
DOI:10.1177/0148607101025003114